Subscribe to our Newsletters !!
Although copying the blueprint is extremely comple
Eppendorf introduces a new addition to their Eppen
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
Drug firm Jubilant Life Sciences on Saturday said it has introduced 1,000 vials of antiviral drug Remdesivir that it sells under the brand name’JUBI-R’ into Uttar Pradesh Chief Minister Yogi Adityanath.
The drug has been made accessible to over 1,000 hospitals supplying COVID-19 treatment in India throughout the organization’s distribution system, Jubilant Life Sciences said in a statement.
“Remdesivir is an effective medication in the treatment of severe COVID-19 instances. In this critical situation, I am pleased that this medicine was made available by Jubilant at the brief period of 2 and a half a year,” the firm quoted Adityanath as stating.
In May 2020,” Jubilant entered into a non-exclusive licensing agreement with Gilead Sciences, Inc., which granted it the right to enroll, fabricate and promote Gilead’s investigational drug remdesivir in 127 countries including India, the company said.
